Kaitlyn McLachlan, PhD

Department of Psychology, University of Guelph

Evaluating novel neurobiomarkers in the identification of adults with FASD using portable eye tracking and EEG technology

Individuals with fetal alcohol spectrum disorder (FASD) are overrepresented in the criminal justice system. There is an urgent need to identify neurobiomarkers of FASD and individuals at risk in order to reduce recidivism and the resulting high social, health, and economic costs. Novel use of neurotechnologies, including portable eye movement control tracking and EEG, may offer a window into the brain and aid in the identification of patterns of deficits in offenders with FASD.
In this study, Dr McLachlan aims to extend the use of these neurotechnologies, normally used in children with FASD, in order to evaluate whether they can reliably identify justice-involved adults at risk of having FASD. The study will also evaluate relationships between performance on eye movement control tasks, and patterns of EEG activation. Findings will be used to develop and implement fast, non-invasive, and affordable screening protocols to aid in large-scale screening for FASD in order to better support those with the disability.

Kaitlyn McLachlan, recipient of a 2016 Banting Research Foundation Discovery Award
Kaitlyn McLachlan, PhD, recipient of a 2016 Banting Research Foundation Discovery Award